DeutschNewstral
Article
Reuters on 2020-12-01 09:08
Grünenthal übernimmt Rechte an AstraZeneca-Cholesterinsenker
Related news
- AstraZeneca verkauft Arzneimittelrechte an GrünenthalReuters
- Bayer übernimmt Rechte an zwei Krebsmitteln von Partner LoxoReuters
- Abkommen mit britischer Behörde soll Novartis-Cholesterinsenker Schub gebenReuters
- FAstraZenecaft.com
Grünenthal GmbH v. Alkem Labs. Ltd.jdsupra.com
EU asks for big penalties against AstraZeneca over dose delaystimesofmalta.com
AstraZeneca: COVID-19 vaccine 'highly effective' preventionStar Tribune
AstraZeneca: COVID-19 vaccine ‘highly effective’ preventionpressherald.com
Agency urges 2nd AstraZeneca shotnwaonline.com
AstraZeneca says vaccine delivery tal...Shropshire Star- Bank Bär übernimmt Mehrheit an mexikanischem VermögensverwalterReuters
EU regulator finds possible link between AstraZeneca vaccine and rare blood clotsreuters.com- VAstraZeneca vaccine recipients can get another AstraZeneca vaccine or an mRNA vaccinevoiceonline.com
AstraZeneca and Oxford say COVID-19 vaccine shows 70% efficacyThe Japan Times
AstraZeneca says COVID-19 vaccine ‘up to 90% effective’reviewjournal.com- HAstraZeneca, J&J Resuming U.S. Tests of COVID-19 Vaccineshamodia.com
- AstraZeneca, J&J vaccine trials back on track in UStimesofmalta.com
AstraZeneca says vaccine ‘highly effective’ at preventing COVID-19bangordailynews.com